ReviewPharmaceuticals (Basel, Switzerland)2021

MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Chao-Ju Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.